Advertisement
Loading...

CytoDyn Inc.

CYDY•PNK
Healthcare
Biotechnology
$0.34
$-0.01(-2.18%)
U.S. Market is Open • 15:52

CytoDyn Inc. (CYDY) Stock Overview

Explore CytoDyn Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap471.3M
P/E Ratio-11.57
EPS (TTM)$-0.04
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$0.20
3 Months$0.39
1 Year Target$0.33

CYDY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CytoDyn Inc. (CYDY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.33.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.57 and a market capitalization of 471.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.62%
5-Day Change
-5.96%
1-Month Change
-6.72%
3-Month Change
29.41%
6-Month Change
17.27%
Year-to-Date (YTD) Change
23.93%
1-Year Change
-10.13%
3-Year Change
33.72%
5-Year Change
-80.83%
All-Time (Max) Change
-46.62%

Contact Information

https://www.cytodyn.com
360 980 8524
1111 Main Street, Vancouver, WA, 98660

Company Facts

9 Employees
IPO DateDec 13, 2006
CountryUS
Actively Trading

Frequently Asked Questions